Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-22-000121
Filing Date
2022-07-06
Accepted
2022-07-06 06:28:15
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165710328185839.html 4  
1 FORM 4 wf-form4_165710328185839.xml 4 13312
  Complete submission text file 0001395064-22-000121.txt   15446
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 221067361
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE TAKEDA PARKWAY DEERFIELD IL 60015
Business Address ONE TAKEDA PARKWAY DEERFIELD IL 60015 2245546500
Takeda Pharmaceuticals U.S.A., Inc. (Reporting) CIK: 0001716229 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 221067360